Rethinking Glioblastoma Therapy: MDA-9/Syntenin Targeted Small Molecule

被引：13
|
作者：
Das, Swadesh K. [1 ,2 ,3 ]
Sarkar, Devanand [1 ,2 ,3 ]
Cavenee, Webster K. [4 ]
Emdad, Luni [1 ,2 ,3 ]
Fisher, Paul B. [1 ,2 ,3 ]
机构：
[1] Virginia Commonwealth Univ, Dept Human & Mol Genet, Sch Med, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Sch Med, VCU Inst Mol Med, Richmond, VA 23298 USA
[3] Virginia Commonwealth Univ, Sch Med, VCU Massey Canc Ctr, Richmond, VA 23298 USA
[4] Univ Calif San Diego, Ludwig Inst Canc Res, San Diego, CA 92093 USA
来源：
ACS CHEMICAL NEUROSCIENCE | 2019年 / 10卷 / 03期
关键词：
Glioblastoma multiforme; MDA-9/Syntenin; invasion; pathogenicity;
D O I：
10.1021/acschemneuro.9b00016
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Effective therapies for glioblastoma multiforme (GBM) are not currently available. A small molecule has been identified using fragment-based drug-discovery guided by NMR that targets important protein-protein interactions controlling GBM invasion and pathogenicity. This first generation drug displays excellent pharmacokinetic properties, passes through the blood-brain barrier and is effective in preclinical animal models of GBM, particularly when combined with radiation therapy.
引用
收藏
页码：1121 / 1123
页数：5
相关论文
共 50 条
  • [21] MDA-9/syntenin interacts with ubiquitin via a novel ubiquitin-binding motif
    Okumura, Fumihiko
    Yoshida, Koichi
    Liang, Fei
    Hatakeyama, Shigetsugu
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2011, 352 (1-2) : 163 - 172
  • [22] MDA-9/Syntenin as a therapeutic cancer metastasis target: current molecular and preclinical understanding
    Das, Swadesh K.
    Fisher, Paul B.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2025, 29 (03) : 75 - 92
  • [23] MDA-9/Syntenin (SDCBP) promotes self renewal and malignancy in cancer stem cells
    Talukdar, Sarmistha
    Das, Swadesh
    Pradhan, Anjan K.
    Emdad, Luni
    Shen, Xue-Ning
    Windle, Jolene J.
    Sarkar, Devanand
    Fisher, Paul B.
    CANCER RESEARCH, 2016, 76
  • [24] mda-9/Syntenin在肿瘤转移过程中的作用
    谭云
    钟东
    重庆医学, 2013, 42 (30) : 3694 - 3696
  • [25] Mda-9/Syntenin在肿瘤进展中的作用研究进展
    周菊兰
    周中银
    疑难病杂志, 2019, 18 (04) : 424 - 427+432
  • [26] Novel Role of MDA-9/Syntenin in Regulating Urothelial Cell Proliferation by Modulating EGFR Signaling
    Dasgupta, Santanu
    Menezes, Mitchell E.
    Das, Swadesh K.
    Emdad, Luni
    Janjic, Aleksandar
    Bhatia, Shilpa
    Mukhopadhyay, Nitai D.
    Shao, Chunbo
    Sarkar, Devanand
    Fisher, Paul B.
    CLINICAL CANCER RESEARCH, 2013, 19 (17) : 4621 - 4633
  • [27] Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells
    Talukdar, Sarmistha
    Das, Swadesh K.
    Pradhan, Anjan K.
    Emdad, Luni
    Shen, Xue-Ning
    Windle, Jolene J.
    Sarkar, Devanand
    Fisher, Paul B.
    ONCOTARGET, 2016, 7 (34) : 54102 - 54119
  • [28] MDA-9/Syntenin regulates protective autophagy in anoikis-resistant glioma stem cells
    Talukdar, Sarmistha
    Pradhan, Anjan K.
    Bhoopathi, Praveen
    Shen, Xue-Ning
    August, Laura A.
    Windle, Jolene J.
    Sarkar, Devanand
    Furnari, Frank B.
    Cavenee, Webster K.
    Das, Swadesh K.
    Emdad, Luni
    Fisher, Paul B.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (22) : 5768 - 5773
  • [29] mda-9/syntenin:: recent insights into a novel cell signaling and metastasis-associated gene
    Sarkar, D
    Boukerche, H
    Su, ZZ
    Fisher, PB
    PHARMACOLOGY & THERAPEUTICS, 2004, 104 (02) : 101 - 115
  • [30] Regulation of neuroblastoma migration, invasion, and in vivo metastasis by genetic and pharmacological manipulation of MDA-9/Syntenin
    Bhoopathi, Praveen
    Pradhan, Anjan K.
    Bacolod, Manny D.
    Emdad, Luni
    Sarkar, Devanand
    Das, Swadesh K.
    Fisher, Paul B.
    ONCOGENE, 2019, 38 (41) : 6781 - 6793
12345